[미국특허]
Method for identifying optical contrast enhancing agents
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
G01N-021/00
G01N-027/00
A61B-005/055
출원번호
US-0326244
(1999-06-04)
발명자
/ 주소
Hochman, Daryl W.
출원인 / 주소
Cytoscan Sciences LLC
대리인 / 주소
Benado Lisa N.
인용정보
피인용 횟수 :
21인용 특허 :
19
초록▼
Optical detection techniques for the assessment of the physiological state, health and/or viability of biological materials are provided. Biological materials which may be examined using such techniques include cells, tissues, organs and subcellular components. The inventive techniques may be employ
Optical detection techniques for the assessment of the physiological state, health and/or viability of biological materials are provided. Biological materials which may be examined using such techniques include cells, tissues, organs and subcellular components. The inventive techniques may be employed in high throughput screening of potential diagnostic and/or therapeutic agents.
대표청구항▼
1. A method for identifying optical contrast enhancing agents useful for enhancing the sensitivity of optical detection of a biological material comprising:maintaining at least one sample population of the biological material in one of the following systems: a cell culture system; a tissue culture s
1. A method for identifying optical contrast enhancing agents useful for enhancing the sensitivity of optical detection of a biological material comprising:maintaining at least one sample population of the biological material in one of the following systems: a cell culture system; a tissue culture system; an organ culture system; and an intact organism;exposing the at least one sample population to a candidate optical contrast enhancing agent;illuminating the at least one sample population with electromagnetic radiation (emr);acquiring test data relating to one or more optical properties of the sample population subsequent to exposure to the candidate optical contrast enhancing agent;comparing the test data acquired to comparison data relating to the one or more optical properties of the sample population, the comparison data being derived from empirically determined controls, whereby changes in the one or more optical properties reflected in the test data compared to the comparison data represent the optical contrast enhancing activity of said agent in said sample population; andbased on the comparison data, determining if the optical contrast enhancing agent is useful for distinguishing pathological cells or tissue. 2. A method for identifying optical contrast enhancing agents useful for enhancing the sensitivity of optical detection of a biological material comprising:maintaining at least one sample population of the biological material in one of the following systems: a cell culture system; a tissue culture system; an organ culture system; and an intact organism;exposing the at least one sample population to a candidate optical contrast enhancing agent;illuminating the at least one sample population with electromagnetic radiation (emr) having a wavelength of from 700-2500 nm;acquiring test data relating to one or more optical properties of the sample population subsequent to exposure to the candidate optical contrast enhancing agent;comparing the test data acquired to comparison data relating to the one or more optical properties of the sample population, whereby changes in the one or more optical properties reflected in the test data compared to the comparison data represent the optical contrast enhancing activity of said agent in said sample population; andbased on the comparison data, determining if the optical contrast enhancing agent is useful for distinguishing pathological cells or tissue. 3. The method of claim 1 or 2, additionally comprising maintaining multiple sample populations in an in vitro culture system. 4. The method according to claim 1, or 2 , wherein the biological material is a viable, intact organism. 5. A method for identifying optical contrast enhancing agents useful for enhancing the sensitivity of optical detection of a biological material comprising:maintaining multiple sample populations in an in vitro culture system;exposing the sample populations to a candidate optical contrast enhancing agent;illuminating the sample populations with electromagnetic radiation (emr);acquiring test data relating to one or more optical properties of the sample populations subsequent to exposure to the candidate optical contrast enhancing agent;comparing the test data acquired to comparison data relating to the one or more optical properties of the sample populations whereby changes in the one or more optical properties reflected in the test data compared to the comparison data represent the optical contrast enhancing activity of said agent is said sample populations andbased on the comparison data, determining if the optical contrast enhancing agent is useful for distinguishing pathological cells or tissue. 6. The method according to claim 1 or 5, wherein the biological material is an organ culture system. 7. A method for identifying optical contrast enhancing agents useful for enhancing the sensitivity of optical detection of a biological material comprising:maintaining at least one sample population of the bio logical material in a viable intact organism;exposing the at least one sample population to a candidate optical contrast enhancing agent;illuminating the at least one sample population with electromagnetic radiation (emr);acquiring test data relating to one or more optical properties of the sample population subsequent to exposure to the candidate optical contrast enhancing agent;comparing the test data acquired to comparison data relating to the one or more optical properties of the sample population, whereby changes in the one or more optical properties reflected in the test data compared to the comparison data represent the optical contrast enhancing activity of said agent in said sample population; andbased on the comparison data, determining if the optical contrast enhancing magnet is useful for distinguishing pathological cells or tissue. 8. The method of claim 5, 7 or 2 , wherein the comparison data is derived from empirically determined controls. 9. The method of claim 1, 5 , 7 or 2 , additionally comprising acquiring multiple test data sets relating to one or more optical properties of the sample population at multiple, selected spatial locations in the sample population. 10. The method of claim 1, 5 , 7 or 2 , additionally comprising exposing the sample population to a physiological challenge prior to acquiring the test data. 11. The method of claim 10, wherein the physiological challenge is selected from the group consisting of: exposure to a test agent, a test condition, a drug, a hormone, a biological agent, a toxin, an infectious agent, radiation, chemotherapy, deprivation of a metabolite or nutrient, electrical stimulation, inflammatory agent, and oncogen. 12. The method of claim 1, 5 , 7 or 2 , additionally comprising acquiring control data relating to the one or more optical properties of the sample population prior to exposing the sample population to a candidate optical contrast enhancing agent. 13. The method of claim 12, additionally comprising comparing the test data to the control data to assess changes in the one or more optical properties of the sample population representing activity of the candidate optical contrast enhancing agent. 14. The method of claim 1, 5 , 7 or 2 , wherein the test data acquired relates to one or more optical properties selected from the group consisting of: reflection, refraction, diffraction, absorption, scattering, birefringence, refractive index and Kerr effect.
Palcic Branko (Vancouver CAX) MacAulay Calum (Vancouver CAX) Jaggi Bruno (Vancouver CAX) Lam Stephen (Vancouver CA CAX) Profio Amedeus E. (Santa Barbara CA) Hung Jaclyn (Vancouver CAX), Endoscopic imaging system for diseased tissue.
Essenpreis Matthias,DEX ; Haar Hans-Peter,DEX ; Boecker Dirk,DEX ; Knuettel Alexander,DEX, Method for investigating a scattering medium with intensity-modulated light.
Alfano Robert R. (Bronx NY) Yoo Kwong M. (Kuala Lumpur MYX) Tang Guichen (Shanghai CNX), Noninvasive method and apparatus for characterizing biological materials.
Hochman Darryl (22933 Edmonds Way Edmonds WA 98020) Haglund Michael M. (1647 N. 197th Pl. Seattle WA 98133), Solid tumor, cortical function, and nerve tissue imaging methods and device.
Hochman Daryl (22933 Edmonds Way Edmonds WA 98020) Haglund Michael M. (1647 N. 197th Pl. Seattle WA 98133), Solid tumor, cortical function, and nerve tissue imaging methods and device.
Matcher Stephen John,GBX ; Cope Mark,GBX ; Delpy David Thomas,GBX, Spectroscopic method for quantitatively determining the change of concentration of a light or other radiation absorbing.
Bamberger Philippe,ILX ; Leichter Isaac,ILX ; Fields Scott,ILX, System and method for diagnosis of living tissue diseases using digital image processing.
Chapman John R. ; Mathias Jean M.,BEX, Systems for quantifying the illumination characteristics of vessels such as blood processing containers with respect to.
Schomacker,Kevin T.; Meese,Thomas M.; Flewelling,Ross F.; Jiang,Chunsheng; Griffin,Christopher E.; Zelenchuk,Alex, Methods and apparatus for processing spectral data for use in tissue characterization.
Bawendi, Moungi G.; Ferrer, Jorge M.; Lee, W. David; Marshall, Lisa F.; Kirsch, David G., System and method for large field of view, single cell analysis.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.